LIP-01 in Hypercholesterolemia

NCT00966225 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Afexa Life Sciences Inc